OpenFilings
PharmaCyte Biotech, Inc.
Form
8-K
Report Period
2025-10-30
Date Filed
2025-10-31
Time Filed
16:05:33
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
FORM 8-K
PHARMACYTE BIOTECH, INC. 2022 EQUITY INCENTIVE PLAN, AS AMENDED
Filing on SEC Edgar